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Voltage-gated sodium channels are required for the initiation
and propagation of action potentials.Mutations in the neuronal
voltage-gated sodium channel SCN1A are associated with a
growing number of disorders including generalized epilepsy
with febrile seizures plus (GEFS),7 severe myoclonic epilepsy
of infancy, and familial hemiplegic migraine. To gain insight
into the effect of SCN1Amutations on neuronal excitability, we
introduced the human GEFS mutation SCN1A-R1648H into
the orthologousmouse gene. Scn1aRH/RHmice homozygous for
the R1648H mutation exhibit spontaneous generalized sei-
zures and premature death between P16 and P26, whereas
Scn1aRH/ heterozygous mice exhibit infrequent spontane-
ous generalized seizures, reduced threshold and accelerated
propagation of febrile seizures, and decreased threshold to
flurothyl-induced seizures. Inhibitory cortical interneurons
from P5-P15 Scn1aRH/ and Scn1aRH/RH mice demonstrated
slower recovery from inactivation, greater use-dependent
inactivation, and reduced action potential firing compared
with wild-type cells. Excitatory cortical pyramidal neuronswere
mostly unaffected. These results suggest that this SCN1Amuta-
tion predominantly impairs sodium channel activity in inter-
neurons, leading to decreased inhibition. Decreased inhibition
may be a common mechanism underlying clinically distinct
SCN1A-derived disorders.
Heterozygous mutations in the neuronal voltage-gated
sodium channel gene SCN1A are responsible for several disor-
ders including generalized epilepsy with febrile seizures plus
(GEFS),7 severe myoclonic epilepsy of infancy (SMEI), and
familial hemiplegic migraine (1–3). Mutations in SCN1A
account for80%of SMEI cases and 10%ofGEFS cases.Over
half of the more than 600 SCN1A mutations in SMEI patients
result in protein truncation and loss of function, demonstrating
haploinsufficiency of SCN1A (4, 5). In contrast, GEFSmuta-
tions are amino acid substitutions that presumably alter but do
not abolish SCN1A activity.
The amino acid substitutions R1648H and T875M were the
first identified SCN1A-GEFS mutations (1). The R1648H
mutation was identified in a large pedigree with 13 affected
members (1). The phenotypes of the R1648H/ heterozygotes
in this familywere highly variable and included individuals with
only childhood febrile seizures, only afebrile epilepsies such as
generalized tonic clonic seizures (GTCS), absence seizures, and
myoclonic seizures, and both febrile and afebrile seizures (1).
This variation in severity may result from differences in genetic
modifiers or environmental influences (4, 6).
GEFS families with SCN1Amutations have also been iden-
tified in which some affected members display neuropsychiat-
ric deficits and ataxia (7, 8). The range of phenotypes among
GEFS pedigrees that harbor different SCN1Amutations sug-
gests that clinical variability may arise from differences in the
way the mutations alter Nav1.1 function. However, functional
analyses of GEFS mutations in heterologous systems have
failed to reveal clear genotype-phenotype correlations, and dif-
ferent results have been observed when the samemutation was
examined in different expression systems. For example, Nav1.1
channels with the R1648H mutation exhibited faster recovery
from inactivation in Xenopus oocytes (9) but increased persis-
tent current in HEK cells (10). Both of these effects should
increase sodium channel activity. Other GEFS mutations
(D1886Y and R859C) have been predicted to decrease neuronal
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excitability by slowing recovery from inactivation and shifting
the voltage dependence of activation or inactivation (11–13).
To examine the in vivo effects of SCN1Amutations on neu-
ronal function, we first generated transgenic mice that express
a bacterial artificial chromosome (BAC) clone containing the
mouse Scn1a gene into which the R1648Hmutation was intro-
duced (14). Electrophysiological analysis of dissociated cortical
neurons from the transgenic mice revealed decreased sodium
channel function in GABAergic inhibitory interneurons.
Recordings from cortical and hippocampal neurons from two
Scn1a knock-out mouse models of SMEI (15, 16) revealed a
similar specific effect of Scn1a deficiency in GABAergic inter-
neurons, raising the prospect that impaired inhibitory circuits
may be a common feature of disorders that result from SCN1A
mutations.
To develop a more accurate model of the human disease, we
have now introduced the SCN1A-R1648H mutation (1, 9) into
themouse genome by homologous recombination at the Scn1a
locus. Spontaneous generalized seizures in heterozygous
(Scn1aRH/) and homozygous (Scn1aRH/RH) knock-in mutants
as well as the predicted increased susceptibility to experimental
febrile seizures were observed. Electrophysiological analysis of
dissociated cortical neurons from the knock-in mutants
demonstrated delayed recovery from inactivation, increased
use dependent inactivation, and reduced action potential fir-
ing in inhibitory interneurons, which is predicted to reduce
inhibition.
EXPERIMENTAL PROCEDURES
Preparation of the Targeting Construct—The targeting con-
struct consisted of a 4.1-kb 5 arm of homology, a neomycin
cassette flanked by FLP1 recombinase (Frt) sites, and a 4-kb 3
armof homology containing theR1648Hmutation and an addi-
tional silent substitution resulting in a unique EcoRI site. The
final assembled targeting construct was sequenced.
Targeting of the R1648HMutation to the Mouse Scn1a Gene—
The targeting construct was linearized with AvrII, gel-purified,
and electroporated into 129X1/SvJ-derived PAT-5 embryonic
stem (ES) cells. Six hundred neomycin-resistant clones were
selected and screened by PCR amplification for correct target-
ing of the 3 armusing the primer pair F4RH (GGAATAGGAA
CTTCG TTCTG CTCG) and R4RH (GTGTG CAACT
CTCCC TACCA TAAG). Positive clones were then screened
for homologous recombination of the 5 arm by PCR amplifi-
cation using the primer pair F5RH (CAAGT GCTAC TTGCC
CAGCAG) andR5RH (TTCTGAGGCGGAAAGAACCAG).
The PCR reactions were conducted using PCR SuperMix High
Fidelity (Invitrogen) under the recommended conditions.
Southern Blot Hybridization—ES cell clones that amplified
with both PCR screens were next analyzed by Southern blot
hybridization. Tenmicrograms of genomic DNAwere digested
overnight with SpeI, StuI, or BglI and separated by agarose gel
electrophoresis. Gels were soaked with agitation in 0.25 M HCl
for 10 min, 0.5 M NaOH and 1.5 M NaCl for 20 min, and 1.5 M
NaCl and 0.5 M Tris (pH 7.5) for 20min and then transferred by
capillary action to Hybond-XL membranes (Amersham Bio-
sciences) with 10 SSC (1 SSC  0.15 M NaCl and 0.015 M
sodiumcitrate).Membraneswere prehybridized at 65 °C for 2 h
in 7%SDS, 0.25MNa2HPO4 (pH7.2), and 1mMEDTA. External
probes with homology to the region upstream of the 5 arm and
downstream of the 3 armwere PCR-amplified with the primer
pair 5F (CAAGC AGAGC TGTTG GCTGA GGT) and 5R
(AGTGT GTAGT TGTAG GTCAT TTGGA GAC) and the
pair 3F (GGACT TCCTA GAATG GCCCC TCAG) and 3R
(CCAAG CGTAA CCATG CTGTA TTTC), respectively. An
internal probewith homology to the 5 armwas amplified using
the primer pair 5intF (CATTA GGAAG GTTTA GATCC
ACTG) and 5intR (CCTAC CTATT CAACC AACCA
AAAT). Each probe was radiolabeled with [-32P]CTP using
the Megaprime DNA Labeling System (Amersham Bio-
sciences), purified using MicroSpin G50 columns (Amersham
Biosciences), and added to the prehybridization buffer for over-
night incubation of the membrane. Membranes were washed
twice with 2 SSC and 0.1% SDS, once with 1 SSC and 0.1%
SDS, and once with 0.2 SSC and 0.1% SDS at 65 °C for 15min.
Clones identified as correctly targeted were confirmed to have
normal karyotypes by chromosome analysis. Southern blot
analysis of genomic DNA from tail biopsies of 5-week-old mice
was performed as described for the ES cell clones.
Generation of Scn1aRH/ and Scn1aRH/RHMice—Two clones
with the R1648H mutation were injected into blastocysts
obtained from mating C57BL/6NCrl female mice with
(C57BL/6J X DBA/2J)F1 male mice at the University of Michi-
gan Transgenic Core. Male chimeras with a high percentage of
agouti coat color were bred to Tg(ACTFLPe)9205Dym/J
females expressing FLP1 recombinase to test for germ line
transmission of the mutation and to delete the neomycin cas-
sette. Scn1aRH/;Tg(ACTFLPe)9205Dym transgene-positive
male offspring were bred to C56BL/6J females to produce
Scn1aRH/ N1 males. N1 males lacking the FLPe transgene
were crossed to C57BL/6J females to create the N2 generation.
All experiments on heterozygous mice were conducted at the
N2 generation. Scn1aRH/ N2 males and females were crossed
to obtain Scn1aRH/RHmice.Mice weremaintained at 22 °C on a
12-h light/dark cycle. Food andwaterwere available ad libitum.
All experiments were performed in accordance with the Insti-
tutional Animal Care andUseCommittees of EmoryUniversity
and the University of California, Irvine.
Genotyping of Mutants—To screen for the R1648H muta-
tion, tail DNA was amplified using the Scn1a-specific primer
pair FRH (TTGATGACTTCTTCACTGATTGAT) and RRH
(AGAGG CTCTG CACTT TCTTC). PCR amplification was
performed for 32 cycles of 94 °C for 30 s, 55 °C for 30 s, and
72 °C for 45 s. The 591-bp PCR product was digested with
EcoRI to distinguish between the wild-type (WT; 591 bp) and
mutant (461 bp) alleles. The primers and the PCR conditions
provided by The Jackson Laboratory (Bar Harbor, ME) for the
B6;SJL-Tg(ACTFLPe)9205Dym/J strain were used to genotype
for the presence of the FLPe transgene. To screen for the dele-
tion of the neomycin cassette, tail DNA was amplified with
primers flanking the cassette, NeoF (TTTTCAAGTCAGGGT
TCCTC), NeoR (GCAGG AAGGG ACATC ATCAG). PCR
amplification was performed for 32 cycles of 94 °C for 30 s,
55 °C for 30 s, and 72 °C for 2.5 min. In the presence of the
neomycin cassette, a 2.5-kb product was observed, whereas
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deletion of the neomycin cassette produced a 767-bp product
from the targeted allele.
Northern Blot Analysis—Northern blot analysis was per-
formed on mRNA from the whole brains of 5-week-old mice.
Two micrograms of poly(A) RNA was separated by electro-
phoresis on an agarose gel containing 10% formaldehyde and
1 MOPS. RNA was capillary-transferred with 10 SSC to
Hybond-XL membrane (Amersham Biosciences). Membranes
were treated as previously described for Southern blot analysis.
A published Scn1a probe (17) and the DECAtemplate glyceral-
dehyde-3-phosphate dehydrogenase-mouse probe (Ambion)
were radiolabeled, purified, and hybridized as in the Southern
blot analysis.
Western Blot Analysis—Western blot analyses from P18 or
5-week-old mouse brains were performed as previously
described (18). With each sodium channel antibody, two mice
of each genotype were analyzed in duplicate on three separate
gels, and protein levels were compared between mutants and
wild-type littermates. Briefly, 30–100 g of protein was sepa-
rated on 7.5% SDS-polyacrylamide gels and blotted with anti-
Nav1.1 (Chemicon, 1:200), anti-Nav1.2 (Alomone, 1:200), anti-
Nav1.3 (Alomone, 1:200), or anti-Nav1.6 (Alomone, 1:200)
antibodies. Horseradish peroxidase -conjugated goat anti-rab-
bit secondary antibody (GE Healthcare) was diluted 1:5000. To
correct for variation in protein loading, themembrane was also
incubated with mouse anti--tubulin diluted 1:10,000 (Cedar-
lane Labs) followed by incubationwith horseradish peroxidase-
conjugated goat anti-mouse IgG (Jackson ImmunoResearch).
Signal was visualized by chemiluminescent detection with the
ECL detection system (GE Healthcare), and the intensity of
each band was quantified using the Gel Logic 2200 Digital
Imaging System (Eastman Kodak Co.) and normalized to the
level of -tubulin.
KainicAcid Seizure Induction—Kainic acid seizure induction
was conducted as previously described (6). Mice between three
and sixmonths of agewere injected intraperitoneally with 15 or
20mg/kg kainic acid (Ocean Produce International).Micewere
observed for 2 h after the injection of kainic acid and scored
according to a modified Racine scale (19).
Flurothyl Seizure Induction—Flurothyl seizure inductionwas
performed as previously described (6). Mice (3–4 months old)
were exposed to flurothyl(2,2,2-trifluroethylether) (Sigma) at a
rate of 20 l/min. The latencies to the first myoclonic jerk and
to the GTCS were recorded. Progression of the tonic-clonic
seizure to tonic hind-limb extension was also noted.
Valproic acid (VPA, Sigma) was dissolved in 0.9% saline and
administered at 100, 200, or 300 mg/kg. VPA or saline was
injected intraperitoneally 30 min before seizure induction. All
experimentswere carried out between 12 and 4 p.m.The exper-
imenter was blind to the genotypes of the mice. Male and
female data were analyzed separately. There were no observed
sex differences in the data; therefore, data from both sexes were
combined.
Experimental Febrile Seizure Induction and Analysis—The
experimental febrile seizure paradigm was modified from
methods published for the rat (20) and adapted to the mouse
(21). Briefly, 14–15-day-old mice were exposed to hyperther-
mia (i.e. increased body and brain temperatures) via a warmed
air stream. Core temperatures were measured before hyper-
thermia induction and at the onset of the seizures. The latter
were considered threshold temperatures. In addition, the rate
of seizure propagation was estimated by examining the pro-
gression of phenomenology of the seizure. The onset of exper-
imental febrile seizures usually involves sudden immobility,
reduced response to stimulation (altered consciousness), and
facial automatisms. These rarely progress to generalized sei-
zures. Because of altered seizure progression in the mutant
mice, the latency and threshold temperature to generalized,
tonic seizures were also determined. Once threshold and
latency were determined, the hyperthermia was discontinued
to stop the seizure. All experiments were carried out between
8 a.m. and 1 p.m., and the experimenter was blind to the
genotypes.
Electroencephalography—Fourteen Scn1aRH/ mice and
nineWT littermates (3–5months old) were implanted for elec-
troencephalography (EEG) recordings as previously described
(6). After a minimum of 7 days recovery from surgery, each
mouse was placed into a Plexiglas box (15  15  15 cm) and
attached to a series of bioelectric amplifiers (Embla Somno-
logica, Iceland) via a small counterbalanced commutator
(Dragonfly Research). After 24 h of acclimatization, EEG and
electromyography data were collected for 96 h from each
mouse, and epileptiform activity was manually scored. Mouse
behavior was also simultaneously monitored with digital video
recording. Seizures were characterized by polyspike activity
accompanied by stereotypic seizure behaviors and a refractory
period. Interictal epileptiform activity was characterized by
spike discharges that were at least two times the amplitude of
the background.
Electrophysiological Recordings—Mice were decapitated
after anesthesia with either ice (P5-P10) or halothane (P13-
P15), and dissociated cortical neurons were prepared as
described previously (22, 23). Excitatory pyramidal neurons
and inhibitory bipolar neurons were identified by correlating
shape with staining for anti-GluR1 (glutamate receptor 1)
(1:5000, Upstate Biotechnology) and anti-GAD67 (glutamic
acid decarboxylase 67) (1:5000, Chemicon), respectively (24,
25). Secondary antibodies Alexa Fluor 568-anti-rabbit IgG and
Alexa Fluor 488-anti-mouse IgG2a (Molecular Probes) were
used for observation with epifluorescent illumination.
Electrophysiological recordings were performed within
24–36 h of obtaining neuronal cultures at 22–25 °C in the
whole-cell patch configuration using an Axopatch 200B patch
clamp with Digidata 1322A interface and pCLAMP 8 software.
The bath solution consisted of 150 mMNaCl, 3 mM KCl, 15 mM
tetraethylammonium chloride, 4 mM BaCl2, 0.1 mMCdCl2, and
10 mMHEPES (pH 7.4), and the electrode solution consisted of
140mMCsF, 10mMNaCl, 5 mM EGTA, and 10mMHEPES (pH
7.3). Series resistance was compensated to 80–90%, and linear
leak subtraction was used for all recordings. Corrections were
made for leak and capacity currents using P/4 subtraction. Cur-
rents were filtered at 5 kHz and sampled at 20 kHz.
Current densities were determined in neurons fromP13-P15
mice at room temperature (22–25 °C) in voltage clamp mode
during a 15-ms depolarization to5mV from a holding poten-
tial of 70 mV. Series resistance was less than 20 megaohms,
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MARCH 26, 2010•VOLUME 285•NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 9825
and the current amplitudes were normalized to cellular capac-
itance. Statistical significance was determined using Student’s t
test.
The voltage dependence of activation and inactivation, re-
covery from inactivation, and use-dependent inactivation were
studied using protocols described by Spampanato et al. (9).
Briefly, the voltage dependence of activationwas analyzedusing
a protocol with depolarizations from60 to15 mV in 5-mV
intervals. Peak current amplitudes were converted to conduct-
ance values, normalized for comparison, and plotted against
voltage. The voltage dependence of inactivation was analyzed
using varying depolarizations for 50 ms to allow inactivation
followed by repolarization and then depolarizing to a test
potential of 15 mV to elicit the remaining available current.
Peak currents during the test pulse were normalized for
comparison and plotted against the voltage of the conditioning
pulse. Recovery from inactivation was analyzed using a pro-
tocol that first inactivated the channels by depolarization to5
mV for 50 ms followed by recovery at 80 mV for a variable
period of time (2 to 60 ms) and a test pulse to 5 mV. Peak
current amplitudes during the test pulse were normalized to
peak current amplitudes during the conditioning pulse and
plotted against recovery time. Use-dependent inactivation was
examined by successive depolarizations to5mV from a hold-
ing potential of 80 mV at 10 and 39 Hz. Measurement of
persistent current was done using prolonged 200-ms depolar-
izations to 10 mV. Each voltage step was followed by a 5-s
recovery period at 80 mV to minimize the accumulation of
use-dependent inactivation. Pulse generation, data collection,
and analyses were done with pCLAMP 8.0, Excel, and Sig-
maPlot 9.0 software. Data shown are the means  S.E., and
statistical significance was determined using Student’s t test.
The average values of the parameters of activation, inactiva-
tion, recovery from inactivation, and use-dependent inactiva-
tion shown inTables 2 and 3were obtained after fitting the data
with the following equations. For activation, G  1/(1 
exp(0.03937z(V V1⁄2)), in which G is conductance, z is the
apparent gating charge,V is the potential of the given pulse, and
V1⁄2 is the potential for half-maximal activation. For inactiva-
tion, I  1/(1  exp(V  V1⁄2)/a), in which I is equal to the
test-pulse current amplitude, V is the potential of the condi-
tioning pulse, V1⁄2 is the voltage for half-maximal inactivation,
and a is the slope factor. For recovery: I 1 Aexp(t/) c,
in which A is the fraction of current that recovered with the
time constant , t is the recovery time, and c is the fraction of
current that did not recover. For use-dependent inactivation:
I  A1exp(t/)  c (single exponential), in which A1 is the
relative fraction of current that decayed with the time constant
, t is the decay time, and c is the remaining current.
Current-clamp recordings were performed on dissociated
cortical neurons from P8-P10mice within 48 h of culture. Neu-
rons were visualized using infrared differential interference
contrast optics and selected based on shape. Recordings were
performed at room temperature (22–25 °C) using aMulticlamp
700A patch clamp amplifier and pClamp 10.2 software (Molec-
ular Devices). Signals were sampled at 25 kHz and filtered at 10
kHz. The pipette solution contained 126 mM potassium gluco-
nate, 4 mM KCl, 10 mM HEPES, 4 mM Mg-ATP, 0.3 mM Tris-
GTP, 10 mM phosphocreatine, pH 7.2. The bath solution con-
tained 126 mM NaCl, 1.25 mM NaH2PO4, 2.5 mM KCl, 2 mM
CaCl2, 2 mM MgCl2, 26 mM NaHCO3, and 10 mM glucose, pH
7.3. After forming a seal and performing capacitance and series
resistance compensations, the passive properties of the cells
were recorded in voltage clampmode. Before switching to cur-
rent-clamp mode, the resting membrane potential was mea-
sured, and only neurons with resting potentials between 55
and 70 mV were used. Firing patterns were recorded in
response to 2-s depolarizing current injections in 20-pA incre-
ments starting at 10 pA. Hyperpolarizing current in steps of
5-pA decrements was injected to measure the input resistance,
and neurons with input resistance of 60–80 megaohms were
selected for analysis. The number of action potentials in 2 s was
counted, and only over-shooting action potentials more posi-
tive than 0 mV were included. Data are represented as the
means S.E. Statistical significance was determined using Stu-
dent’s t test with p	 0.05 as the criterion for significance.
RESULTS
Targeted Insertion of the R1648H Mutation into the Mouse
Scn1a Gene—We generated a mouse model of human GEFS
by knocking in the SCN1A-R1648H mutation into exon 26 of
the mouse Scn1a gene (Fig. 1A). This mutation resulted in the
substitution of a positively charged arginine residue in the volt-
age sensor of domain 4 with a histidine residue (1). Six hun-
dred neomycin-resistant ES cell clones were screened for
correct targeting by PCR amplification of the 3 and 5
regions of homology (Fig. 1B). Clones that were positive in
both PCR assays were examined by Southern blot analysis.
Two correctly targeted ES cell clones were injected into blasto-
cysts to generate chimeric mice that were bred to generate the
knock-inmice. The presence of the targeted allele in the result-
ing lines of mice was confirmed by Southern blot analysis with
5 and 3 probes (Fig. 1C).
Northern blot analysis of mRNA from the whole brains of
Scn1aRH/ mice detected the expected full-length Scn1a tran-
script. The expression level of the Scn1a transcript was compa-
rable in heterozygous Scn1aRH/mutants and WT littermates
(Fig. 2A). Western blot analysis of protein extracts from the
whole brains of P18 Scn1aRH/ and Scn1aRH/RH mutants (Fig.
2B) and 5-week-old Scn1aRH/mutants (Fig. 2C) revealed lev-
els of Nav1.1, Nav1.2, Nav1.3, and Nav1.6 that were comparable
with WT littermates. Only full-length Nav1.1 protein was
detected in themutants (supplemental Fig. 1). These data dem-
onstrate the in vivo stability of the R1648H transcript and the
mutant channel protein.
Homozygous Scn1aRH/RH Mutants Exhibit Spontaneous Sei-
zures and Shortened Life Span—Scn1aRH/RH mutants were
visually indistinguishable from Scn1aRH/mice andWT litter-
mates until approximately P16. Beginning at P16, recurrent vis-
ible seizureswere observed in Scn1aRH/RHmice. The behavioral
seizures typically lasted 30–90 s and were characterized by
excessive jumping, repetitive jerking of all four limbs, head nod-
ding, and clonus of the forelimbs and tail. Some behavioral sei-
zures ended with hindlimb extension, typical of severe seizures
in the mouse. The life span of the Scn1aRH/RH mutants was
16–26 days, with a mean life span of 18.5 days (Fig. 3A). The
MouseModel of SCN1ADysfunction
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phenotype of Scn1aRH/RH homozygotes is very similar to
homozygous null mice (15, 16), indicating that the R1648H
mutation has a more profound effect in vivo than suggested by
earlier studies in heterologous expression systems.
Before seizure onset, Scn1aRH/RHmutants gained weight at a
rate similar to Scn1aRH/ and WT littermates. From approxi-
mately P15, body weight began to decrease, and by P18 the
average weight of Scn1aRH/RH mice was 23% lower than their
littermates (p  1.0  107) (Fig. 3B). Feeding behavior
appeared to be normal, and excessive separation from the dam
was rarely observed.
Nissl staining of brain sections from P18 homozygous and
five-month-old heterozygous mutants revealed normal brain
morphology and no gross reduction in cell density in the hip-
pocampus or cortex compared with WT littermates. Neuronal
cell abundance was investigated using the neuron-specific
marker NeuN. Neither Scn1aRH/ nor the Scn1aRH/RHmutants
displayed a loss of NeuN immunoreactivity, demonstrating
normal neuronal cell viability (data not shown).
Heterozygous Scn1aRH/ Mutants Exhibit a Low Level of
Spontaneous Seizures—EEG recordings were obtained for a
period of 96 h from each of 14 freely moving 3–5-month-old
Scn1aRH/ mutants (1344 h total) and 9 age-matched WT lit-
termates (864 h total). Generalized seizures were detected in
two Scn1aRH/mutants. In thesemice a total of 21 spontaneous
generalized seizures were recorded during the combined 192 h
of EEG analysis. Representative recordings are shown for a
wild-type control (Fig. 4A) and a heterozygousmutant (Fig. 4,B
and C). The seizures in the Scn1aRH/ mutants involved both
hemispheres of the brain and were characterized by spike dis-
charges that were at least two times
the amplitude of the background
(Fig. 4C). The average duration of
the seizures was 32.9 1.8 s. All sei-
zures were associated with stereo-
typic motor behaviors and were fol-
lowed by a refractory period with an
average length of 62.4  12.7 s.
Spontaneous seizures have also
been observed in additional
Scn1aRH/ mutants during routine
mouse colony management proce-
dures. Seizures and spike discharges
were not observed in the EEG
recordings from the WT mice. The
observation of spontaneous seizures
in only two Scn1aRH/ mutants is
likely due, in part, to the mixed
genetic background and is consis-
tent with the variability observed
among affectedmembers of GEFS
families. A variable incidence of
spontaneous seizures was also
observed in Scn1a/ mice, with
seizures detected in 3 of 7 mutants
examined (15).
Scn1aRH/ Mice Exhibit Reduced
Thresholds to Flurothyl-induced
and Experimental Febrile Seizures—To determine whether
heterozygosity for the R1648H mutation alters seizure thresh-
olds, we first examined the response to the chemiconvulsant
flurothyl. We measured the latency to the myoclonic jerk, the
first observable behavioral response, and latency to the GTCS
(Fig. 5A). We observed no difference in the latency to the myo-
clonic jerk in Scn1aRH/ mutants. However, Scn1aRH/ mice
exhibited a 19% reduction (p 0.02) in the latency to theGTCS
compared with WT littermates, indicating that GEFS mice
are more susceptible to flurothyl-induced generalized seizures.
VPA is a broad-spectrum anticonvulsant used in the treat-
ment of GEFS patients. We assessed the ability of VPA to
correct the increased susceptibility to flurothyl-induced sei-
zures observed in the mutant mice. Serum levels of VPA corre-
sponding to therapeutic levels in humans can be achieved in
mice by acute administration of 200 mg/kg VPA (26). Single
doses of 100, 200, or 300 mg/kg of VPA or saline control were
administered to Scn1aRH/ mutants and WT littermates.
Thirty minutes after administration of VPA, latency to flu-
rothyl-induced GTCS was measured (Fig. 5B). Injection of 200
or 300 mg/kg of VPA returned the latency of Scn1aRH/
mutants back to WT values (Fig. 5B). The values for latency to
GTCS after 200mg/kgVPAwere 9.7 1.2min inWTmice and
9.2  1.8 min in heterozygous mutants (p  0.53). After 300
mg/kg VPA, the latency was 14.2 3.7 min in WT and 13.1
3.5 min in the mutants (p 0.53).
The seizure thresholds of the Scn1aRH/ mice were also
examined after the administration of kainic acid at doses of 15
and 20 mg/kg. Seizure progression was determined using a
modified Racine scale (19). The response of the heterozygous
FIGURE 1. Generation of the Scn1a GEFS mouse model by targeted knock-in of the human R1648H
mutation.A, shown is an illustration of thewild-type Scn1a locus, the targeting vector, and the targeted Scn1a
allele with the R1648H mutation. StuI, SpeI, and BglI restriction sites, the location of probes for Southern blot
analysis, and the lengths of the predicted restriction fragments are shown. B, PCR screen of neomycin-resistant
ES cell clones., positive clone;, negative clone. C, Southern blot analysis is shown of genomic DNA from
Scn1aRH/ andWTmice after digestionwith SpeI and StuI. After digestionwith SpeI, the 5 probe detected the
expected 17- and 11-kb fragments from theWT and RH allele, respectively. Fragments of 10.9 and 8.6 kb from
theWT and RH allele, respectively, were detected with the 3 probe following digestion with StuI. RH, R1648H.
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mutants was not statistically different from their WT litter-
mates at either dose, indicating that the mutation does not
increase susceptibility to all forms of seizure induction.
Because febrile seizures are a prominent symptom inpatients
with the R1648H mutation, we tested whether the knock-in
mice also demonstrated increased susceptibility to febrile sei-
zures. This was accomplished by
comparing threshold temperatures
and the latency to the onset and
tonic generalization of these sei-
zures in WT, Scn1aRH/, and
Scn1aRH/RH mice. Threshold tem-
peratures for the onset of tonic feb-
rile seizures in Scn1aRH/ and
Scn1aRH/RH mutants were signifi-
cantly lower than those in WT lit-
termates (Fig. 5C, one way analysis
of variance, p 0.0007). In addition,
the latency to the tonic seizure onset
was shorter in Scn1aRH/ and
Scn1aRH/RH mutants (Fig. 5D, one
way analysis of variance, p 0.01).
GABAergic Interneurons Exhibit
Slowed Recovery from Inactivation
and Elevated Use-dependent In-
activation in Scn1aRH/ and
Scn1aRH/RH Mice—To determine
the mechanism by which the
R1648H mutation altered neuronal
excitability, we examined the elec-
trophysiological properties of disso-
ciated cortical neurons usingwhole-
cell voltage clamp. Neurons were
separated into the twomajor classes
of cortical neurons: excitatory pyra-
midal-shaped neurons and inhibi-
tory bipolar-shaped interneurons.
Excitatory pyramidal neurons and
GABAergic interneurons were first
identified by antibody staining to
FIGURE2.Expressionof theCNSvoltage-gatedsodiumchannels isunaltered inR1648Hmutants.A,Northern
blot from Scn1aRH/ andWT littermates revealed comparable expression of the Scn1a transcript. B, Western blot of
brain membrane proteins from Scn1aRH/RH, Scn1aRH/, and WT littermates at P18 demonstrate normal levels of
Nav1.1 and Nav1.3 in the mutants. C, levels of Nav1.1, Nav1.2, and Nav1.6 proteins were comparable in 5-week-old
Scn1aRH/miceandWT littermates. Theexpected260-kDasodiumchannel-subunitproteinbandwasdetected in
allWesternblots. Quantitative analysis of protein levelswasperformedon three separateWesternblots.Bar graphs
of relative protein levels are shown below the representative Western blots. The amount of each sodium channel
proteinwasnormalizedagainst-tubulin.Theratio fromtheWTlittermateswasassignedavalueof1.Graybars,WT;
black bars, Scn1aRH/;white bars, Scn1aRH/RH. RH/, Scn1aRH/; RH/RH, Scn1aRH/RH. Error bars represent S.E.
FIGURE 3. Scn1aRH/RHmutants display shortened life span and reduced bodyweight. A, Scn1aRH/RHmutants exhibited amarked reduction in life span; n
20–40 per group. B, the weight gain of Scn1aRH/mutants andWT littermates are indistinguishable; however, Scn1aRH/RHmutants exhibit a reduction in body
weight beginning at P15; n 20–34 per group. *, p	 0.05 compared with WT. The values shown are the mean S.E.
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glutamate receptor 1 (anti-GluR1)
and glutamic acid decarboxylase 1
(anti-GAD67), as previously de-
scribed (14). We then correlated
immunostaining with cell mor-
phology to identify bipolar-shaped
GABAergic interneurons and
pyramidal-shaped excitatory neu-
rons for patch clamping. We
examined cortical neurons
because of the development of
spontaneous generalized seizures
in the mutant mice. Representa-
tive current traces recorded from
bipolar and pyramidal cortical
neurons from Scn1aRH/,
Scn1aRH/RH, and WT littermates
at P13-P15 are shown in Fig. 6.
Because it was previously ob-
served that the loss of one sodium
channel allele in a mouse model of
SMEI leads to a 40% reduction in
sodium current in bipolar neurons
(15), it was possible that the R1648H
GEFSmutation could also lead to
decreased levels of sodium current.
Therefore, we first determined the
total sodium current in bipolar neu-
rons and pyramidal neurons from
Scn1aRH/, Scn1aRH/RH, and WT
littermates at P13-P15. To account
for differences in cell sizes, the total
current was normalized to the cellu-
lar capacitance, which is directly
proportional to the total quantity of
cell membrane. Bipolar neurons
from WT mice demonstrated a
higher current density than pyram-
idal neurons, with a ratio of 2.70
(Table 1). The higher density in
bipolar neurons is consistent with
previous results from an SMEI
mouse model (15) and from wild-
type mice in which the dendritic
sodium current density in interneu-
rons was approximately three times
higher than the density in principal
neurons (27). In contrast, bipolar
neurons from Scn1aRH/ and
Scn1aRH/RH demonstrated a current
density than was similar to that of
pyramidal neurons, with ratios of
0.94 and 0.95, respectively. There is
a trend toward increased current
density in pyramidal neurons from
Scn1aRH/ and Scn1aRH/RH com-
pared with WT mice, although
these differences were not statisti-
FIGURE 4. Spontaneous seizure in an Scn1aRH/mouse. Representative EEG recordings from a five-month-
old WT mouse and an Scn1aRH/ littermate. A, a normal EEG pattern from an awake WT mouse is shown. B, a
normal EEGpattern froman Scn1aRH/mutant is shown.C, an EEGpattern froman Scn1aRH/mutant during an
ictal episode. Arrowsmark the boundaries of a 32-s polyspike discharge in both hemispheres accompanied by
muscle activity, as indicatedby theelectromyographychannel. The seizurewas followedbya refractoryperiod.
Right EEG, channel recording from right hemisphere. Left EEG, channel recording from left hemisphere; EMG,
channel recording from neck muscle.
FIGURE 5. Scn1aRH/ mutants exhibit reduced seizure thresholds. A, shown is latency in minutes to the
myoclonic jerk (MJ) and the GTCS after exposure to flurothyl in Scn1aRH/mutants and WT littermates. B, VPA
restores normal thresholds to flurothyl-induced seizures in Scn1aRH/mice. Latency in minutes to the GTCS at
100, 200, and 300mg/kg VPA is shown.Gray bars, WT; black bars, Scn1aRH/. *, p	 0.05 comparedwithWT. The
values shownare themean S.E.C, Scn1aRH/ and Scn1aRH/RHmutants aremore susceptible togeneration and
rapid propagation of experimental febrile seizures compared with WT littermates (/). Threshold tempera-
tures for the onset of tonic febrile seizureswere significantly lower in Scn1aRH/RH (40.4 0.65 °C) and Scn1aRH/
mutantmice (43.10.26 °C)whencomparedwithWT littermates (44.10.21 °C). *,p	0.05, one-wayanalysis
of variance. D, latencies to the tonic febrile seizure onset were significantly shorter for the Scn1aRH/mutants
mice compared with the WT mice and were further reduced in the Scn1aRH/RH mutants. *, p	 0.05, one-way
analysis of variance.
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cally significant. These results indicate that the R1648H muta-
tion specifically decreased the total sodium current amplitude
in bipolar neurons.
In addition to the effect on sodium current amplitudes, it was
possible that the R1648H mutation might also alter the func-
tional properties of the channel. Previous studies using heter-
ologous systems have reported effects on activation, inactiva-
tion, use-dependent inactivation, and percentage of persistent
current for this mutation (9, 10, 28). We examined all of these
properties in bipolar and pyramidal neurons from Scn1aRH/,
Scn1aRH/RH, and WT littermates. Neurons were isolated at
P13-P15, the oldest age before the Scn1aRH/RHmutants started
to die, and at P5-P8, before the onset of seizures when Nav1.1
channels begin to be expressed (16).
In cortical bipolar neurons fromP13-P15mutantmice, there
were no significant differences in the voltage dependence of
sodium channel activation or inactivation comparedwith bipo-
lar neurons fromWTmice (Figs. 7,A and B, Table 2). Themost
significant difference was increased use-dependent inactiva-
tion with rapid stimulation. Use-dependent inactivation refers
to the reduction in sodium current that is observed during suc-
cessive depolarizations when there is insufficient time between
depolarizations for the channels to fully recover from inactiva-
tion. With repetitive depolarizations at 39 Hz, neurons from
Scn1aRH/ and Scn1aRH/RH mice demonstrated a greater
decrease in current compared withWTmice (Fig. 7C, Table 2).
A less pronounced effect was observed with repetitive depolar-
izations at 10 Hz, a frequency at which there is only minimal
use-dependent inactivation (Fig. 7D, Table 2). Consistent with
this result, R1648Hneurons also demonstrated slower recovery
from inactivation (Fig. 7E). The time constant for recovery was
significantly larger and the extent of recovery was significantly
reduced in neurons from homozygous and heterozygous mice
(Table 2). Neurons from the mutant mice demonstrated
slightly less persistent current, but this difference was not sta-
tistically significant (Fig. 7F). Similar effects of the R1648H
mutation were observed in bipolar neurons from P5-P8 mice
(Table 2).
Anti-mGluR1-positive pyramidal-shaped neurons from
Scn1aRH/ and Scn1aRH/RH mice showed no significant differ-
ences in most of the functional properties examined. Specifi-
cally, there were no significant differences in the voltage
dependence of activation and inactivation, use-dependent
inactivation, or the percentage of persistent current in neurons
from either P13-P15 or P5-P8 mice (Table 3). The only signifi-
cant difference was that the time constant for recovery from
inactivationwas faster for Scn1aRH/RH comparedwithWTP13-
P15mice. However, the relevance of this effect is unclear, as no
significant differences were observed in use-dependent inacti-
vation at either age, and the difference in recovery time con-
stants was not observed for pyramidal neurons from P5-P8
mice.
GABAergic Interneurons from Scn1aRH/RH Mice Exhibit
Decreased Action Potential Firing—To determine whether the
electrophysiological differences in sodium channel properties
altered neuronal excitability, we measured the number of
action potentials in response to 2-s injections of current in
20-pA increments starting at 10 pA. Sample traces of bipolar
and pyramidal neurons during current injections from 10 to
110 pA are shown in Fig. 8A, and summary data showing the
number of action potentials fired during the 2-s interval are
shown in Fig. 8B. On average, bipolar neurons from WT and
heterozygous Scn1aRH/ mice fired comparable numbers of
action potentials for all magnitudes of current, reaching amax-
imum of 35 action potentials and then tapering off at the
highest levels of current (Fig. 8B), although some cells from
Scn1aRH/ mice showed reduced firing (Fig. 8A). In contrast,
bipolar neurons from homozygous Scn1aRH/RHmice reached a
maximumof only 20 action potentials when 70 pAwas injected,
and the number decreased with successively higher current
injections.
Pyramidal neurons from all three genotypes fired fewer
action potentials, with neurons from WT and heterozygous
Scn1aRH/ mice reaching a maximum of 20 action poten-
tials before decreasing. Pyramidal neurons from homozygous
Scn1aRH/RHmice showed reduced numbers of action potentials
at the lowest current injections, with brief bursts at the begin-
ning of the injection (Fig. 8A). However, the number of action
potentials was comparable with those for neurons from WT
and heterozygous Scn1aRH/mice for current injections above
90 pA, so that it is unclear if the difference at lower levels of
current is physiologically significant. In contrast, the markedly
reduced action potential firing in bipolar neurons from
Scn1aRH/RH mice compared with WT and Scn1aRH/ mice
FIGURE6.Voltage-clamp tracesof sodiumcurrents indissociated cortical
bipolar andpyramidal neurons fromP13-P15mice. Sodiumcurrentswere
recorded from a holding potential of 80 mV during depolarizations from
60 to 15mV in 5-mV steps, although the traces are only shown for depolar-
izations between40 and 10 mV in 10-mV steps. Scale bars indicate 200 pA
and 1 ms.
TABLE 1
Current densities in bipolar and pyramidal neurons
Current densities were determined in neurons from P13–15 mice as described
under “Experimental Procedures.” The values shown are the mean  S.E. pF,
picofarads.
Genotype RH/RH RH/ WT
Bipolar density (pA/pF) 83 10a 60 4a 146 29
Bipolar number of cells 12 8 9
Pyramidal density (pA/pF) 87 14 64 10 54 9a
Pyramidal number of cells 10 7 7
Current ratio (bipolar/pyramidal) 0.95 0.94 2.70
a Statistically significant difference compared to wild-type bipolar neurons (p 	
0.05).
MouseModel of SCN1ADysfunction
9830 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 13•MARCH 26, 2010
indicates that these neurons have reduced excitability, consis-
tent with decreased sodium channel activity.
DISCUSSION
Several characteristics of the R1648H knock-inmice are sim-
ilar to the clinical features of the human GEFS patients, who
are heterozygous for the mutation. Heterozygous Scn1aRH/
mice have normal life spans, reduced thresholds to febrile sei-
zures, and spontaneous seizures. Homozygous Scn1aRH/RH
mutant mice developed spontane-
ous seizures andweight loss starting
at P15, the time when Scn1a expres-
sion approaches adult levels (16).
Generalized seizures were fre-
quently observed in the homozy-
gous mutants, and these mice had
an average life span of 18.5 days.
Because severe convulsive seizures
may impair the autonomic nervous
system and lead to cardiac arrest
(29), premature lethality in these
mice may be due to severe motor
seizures. Consistent with the severe
phenotype of homozygous mice,
there are no known patients with
two mutant SCN1A alleles. In addi-
tion, Scn1aRH/RH mutants also dis-
play jumping, erratic behavior, and
tail clonus in response to mild star-
tle. This hyper-responsive behavior,
which may reflect seizure activity,
was not seen in Scn1aRH/ mice or
WT littermates.
Although the presence of the
R1648H mutation did not affect
Scn1a transcript or protein levels, it
had a significant effect on the elec-
trophysiological properties of corti-
cal interneurons. Increased use-de-
pendent inactivation and slowed
recovery from inactivation were
observed in bipolar interneurons
but not in pyramidal cells, and there
was a decreased ratio of sodium cur-
rent in bipolar to pyramidal neu-
rons. The decreased sodium current
is particularly noteworthy for two
reasons. First, the recordings mea-
sured total somatic currents,
including contributions from the
Nav1.2 and Nav1.6 isoforms,
whereas the R1648H mutation
should only affect Nav1.1. Second,
bipolar and pyramidal neurons each
represent a heterogeneous group of
many different types of neurons,
and it is likely that Nav1.1 is differ-
entially expressed in many of those
cell types. This heterogeneity is reflected in the large standard
errors for the current density measurements in Table 1. We
anticipate that the effects of the R1648Hmutation will be more
pronounced if examined in a homogenous population of inhib-
itory neurons.
The findings from the electrophysiological analysis of the
sodium channel properties in the knock-in mice are consistent
with our previous analysis of cortical interneurons from BAC
transgenic mice expressing the SCN1A-R1648Hmutation (14).
FIGURE 7. Electrophysiological recordings show altered sodium channel properties in dissociated corti-
cal bipolar neurons from P13-P15 mice. A, no differences in voltage dependence of activation are shown.
Sodiumcurrentswere recorded fromaholdingpotential of80mVduringdepolarizations from60 to 15mV
in 5-mV steps, and conductance values were calculated as described under “Experimental Procedures.” Data
were fit with a single exponential equation. B, no differences in voltage dependence of inactivation are shown.
The voltage dependence of inactivation was determined using a two-step protocol with conditioning pulses
from110 to 10mV followed by a test depolarization to5mV. The data were fit with a two-state Boltzmann
equation. C, increased use dependent inactivation at 39 Hz is shown. Currents were elicited by depolarizations
to5 mV from a holding potential of80 mV at a frequency of 39 Hz. The data were fit with a single expo-
nential decay equation. D, shown is increased use-dependent inactivation at 10 Hz. Currents were elicited by
depolarizations to5mV from a holding potential of80mV at a frequency of 10 Hz. The data were fit with a
single exponential decay equation. E, small differences in recovery from inactivation are shown. Currents were
elicitedwith a two-pulse protocol that consisted of a conditioning depolarization to5mV for 50ms followed
by a test depolarization to5mV, with the recovery time between the two pulses decreasing from 60 to 2ms.
Fractional recovery was determined as described under “Experimental Procedures.” The data were fit with a
single exponential equation. F, no differences in persistent current were shown. Persistent current was deter-
mined during a prolonged 200-ms depolarization to10 mV.
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However, we were only able to observe the effects of the muta-
tion in the BAC transgenic mice when the mutant sodium cur-
rents were isolated by recording in the presence of saxitoxin.
The fact that the mutation had comparable effects in homozy-
gous knock-in mice demonstrates that the alterations were not
due to use-dependent block by saxitoxin during recording from
the BAC transgenic mice. In addition, we also observed that
bipolar neurons from Scn1aRH/RH homozygous knock-in mice
exhibit decreased action potential firing compared with neu-
rons fromWT or Scn1aRH/ heterozygous mice. The fact that
decreased firingwas observed only in bipolar and not pyramidal
neurons most likely reflects greater expression of the Nav1.1
TABLE 2
Parameters of sodium channel properties from bipolar neurons
The electrophysiological properties were fit according to the equations described under “Experimental Procedures.” The values shown are the mean S.E.
P5-P8 P13-P15
RH/RH RH/ WT RH/RH RH/ WT
Voltage dependence of activation
Gating charge (z) 3.4 0.7 3.9 0.8 3.5 1.2 5.9 0.9 3.8 0.8 5.8 2.1
V1⁄2 (mV) 21.5 5.1 20.9 5.8 21.1 6.2 31.9 6.4 32.5 4.3 30.3 3.3
n 5 8 3 6 4 8
Voltage dependence of inactivation
Slope (a) 7.9 2.3 9.2 1.7 10.1 1.1 7.2 1.3 9.3 2.5 7.2 1.2
V1⁄2 (mV) 53.5 7.3 58.9 7.2 54.8 6.9 58.4 6.3 58.9 7.3 58.9 6.1
n 5 12 5 6 5 6
Recovery from inactivation
Ratio (a) 0.9 0.23 0.9 0.16 1.1 0.05 0.94 0.12 0.99 0.11 0.95 0.07
1 (ms) 9.5 0.5a 7.6 0.4a 5.1 0.3 9.6 0.2a 10.4 0.4a 7.6 0.1
Fraction recovered 0.8 0.04a 0.9 0.06 0.95 0.02 0.9 0.03a 0.92 0.04 0.94 0.02
n 4 8 5 8 4 6
Use dependence at 39 Hz
Fraction decayed (A) 0.5 0.06 0.4 0.04 0.4 0.02 0.4 0.08 0.3 0.06 0.3 0.03
1 (s) 0.5 0.03a 0.6 0.07 0.7 0.04 0.6 0.08 0.5 0.07a 0.8 0.1
Remaining current (C) 0.2 0.06a 0.4 0.08 0.4 0.09 0.38 0.09 0.4 0.08 0.5 0.09
n 6 19 17 18 8 9
Use dependence at 10 Hz
Fraction decayed (A) 0.1 0.04 0.1 0.04 0.1 0.02 0.3 0.06 0.3 0.08 0.2 0.09
1 (s) 0.6 0.1 0.7 0.08a 0.5 0.02 0.3 0.07a 0.4 0.08a 0.8 0.09
Remaining current (C) 0.8 0.02a 0.8 0.09 0.9 0.06 0.72 0.09a 0.76 0.05 0.86 0.06
n 7 11 14 15 8 10
Persistent current
Percent 0.7 0.1 0.9 0.2 1.0 0.1 0.7 0.1 0.7 0.2 0.9 0.3
n 6 9 11 9 6 7
a Statistically significant difference compared to wild-type neurons (p	 0.05).
TABLE 3
Parameters of sodium channel properties from pyramidal neurons
The electrophysiological properties were fit according to the equations described under “Experimental Procedures.” The values shown are means S.E. of the mean.
P5-P8 P13-P15
RH/RH RH/ WT RH/RH RH/ WT
Voltage dependence of activation
Gating charge (z) 5.0 1.3 6.1 1.2 4.4 0.9 4.4 0.9 4.9 1.2 6.7 0.8
V1⁄2 (mV) 27.6 5.6 26.7 4.9 24.5 5.3 30.9 4.9 31.8 3.7 32.2 5.3
n 6 5 3 4 3 3
Voltage dependence of inactivation
Slope (a) 9.0 1.3 7.3 2.7 8.1 1.9 6.7 1.5 7.0 2.7 7.4 1.9
V1⁄2 (mV) 56.9 7.3 56.6 6.7 52.3 7.2 58.8 4.3 55.2 6.3 55.5 5.2
n 9 6 4 5 5 5
Recovery from inactivation
Ratio (a) 0.9 0.04 1.0 0.07 0.8 0.06 0.98 0.06 0.99 0.07 0.97 0.06
1 (ms) 8.1 0.11 9.4 0.08 9.4 0.06 6.9 0.13a 9.5 0.07 9.3 0.06
Fraction recovered 0.9 0.02 0.9 0.03 0.9 0.03 0.9 0.06 0.9 0.04 0.9 0.05
n 3 8 9 8 4 6
Use dependence at 39 Hz
Fraction decayed (A) 0.5 0.01 0.4 0.03 0.4 0.05 0.3 0.01 0.3 0.04 0.4 0.07
1 (s) 0.6 0.04 0.5 0.07 0.5 0.04 0.4 0.07 0.5 0.09 0.5 0.02
Remaining current (C) 0.3 0.06 0.4 0.09 0.4 0.09 0.3 0.08 0.3 0.06 0.4 0.06
n 5 13 17 8 4 5
Use dependence at 10 Hz
Fraction decayed (A) 0.2 0.01 0.2 0.03 0.2 0.04 0.2 0.004 0.2 0.07 0.25 0.03
1 (s) 0.6 0.1 0.3 0.05 0.3 0.08 0.3 0.03 0.3 0.06 0.3 0.02
Remaining current (C) 0.8 0.08 0.8 0.08 0.8 0.09 0.83 0.06 0.85 0.02 0.81 0.04
n 7 17 19 12 3 7
Persistent current
Percent 0.9 0.2 0.8 0.2 0.7 0.1 0.5 0.1 0.9 0.2 0.8 0.3
n 7 7 19 10 4 6
a Statistically significant difference compared to wild-type neurons (p	 0.05).
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channel in bipolar compared with pyramidal neurons, as we
previously observed in the BAC transgenicmice (14) and others
observed in the Scn1a knock-out mouse models of SMEI (15,
16).
Based on these effects, interneurons containing R1648H
mutant sodium channels would be less reliable in propagating
high frequency trains of action potentials, leading to a reduc-
tion in GABAergic inhibition. Given the importance of inhibi-
tory circuits in controlling the excitability of postsynaptic neu-
rons, it seems likely that reduced firing of cortical interneurons
and possibly other GABAergic interneurons contributes to the
seizure generation in the Scn1aR1648H mouse models. Reduced
inhibition is also consistent with the rapid, abnormal propaga-
tion of experimental febrile seizures in these mice. Most
Scn1aRH/RHmutantmice became immobile (the typical onset of
experimental febrile seizure), then immediately progressed to a
tonic seizure, whereas this progres-
sion was rarely seen in WT or
Scn1aRH/ mice, and when evident
took several minutes to occur.
In contrast to the consistent
results that were observed from the
analysis of cortical interneurons
from the R1648H knock-in and
BAC transgenic mice, differences
between the models were identified
from the analysis of cortical pyram-
idal cells. The only electrophys-
iological abnormalities detected in
cortical pyramidal cells from the
knock-in mice was slightly faster
recovery from inactivation in
homozygous P13-P15 mutants and
a lower number of action potentials
at low current injections. However,
the difference in recovery was small
enough so that it did not result in an
increase in use-dependent inactiva-
tion, and the number of action
potentials at higher levels of current
was comparable with that for WT
mice. In contrast, cortical pyramidal
cells from the BAC transgenic mice
revealed a hyperpolarizing shift in
the voltage dependence of inactiva-
tion (14). The two models also dif-
fered in seizure severity and sus-
ceptibility. The knock-in mice
exhibited spontaneous seizures,
EEG abnormalities and normal
thresholds to kainic acid-induced
seizures. In contrast, BAC trans-
genicmice weremore susceptible to
kainic acid-induced seizures but did
not show spontaneous seizure activ-
ity. Differences between the two
models were not surprising as the
BAC transgene is unlikely to fully
recapitulate the temporal and spatial expression of the endog-
enous Scn1a gene, and the knock-in mice represent a more
accurate disease model.
Functional studies in heterologous expression systems have
failed to identify a common abnormality in SCN1A mutations
from patients with GEFS. In different experimental systems,
biophysical analysis of the R1648Hmutation in Nav1.1 demon-
strated either increased recovery from fast inactivation (9) or
increased persistent current (10). Analysis of the comparable
mutation in Nav1.2 demonstrated a positive shift in the voltage
dependence of inactivation (30), and analysis in Nav1.4 identi-
fied a negative shift in the voltage dependence of activation and
inactivation and increased recovery from fast inactivation (28).
Analyses of other GEFS mutations in heterologous expres-
sion systems have also been difficult to interpret, with the bio-
physical abnormalities of somemutations being consistentwith
FIGURE 8.Decreased action potential firing in dissociated cortical bipolar neurons.A, firing patternswere
recorded during 2-s depolarizing current injections in 20-pA increments, starting at 10 pA. Scale bars indicate
10 mV and 200 ms. B, the number of action potentials during the 2-s current injection is plotted versus the
magnitude of the current. Sample sizes were 10 for bipolar WT, 19 for bipolar Scn1aRH/, 12 for bipolar
Scn1aRH/RH, 7 for pyramidal WT, 5 for pyramidal Scn1aRH/, and 4 for pyramidal Scn1aRH/RH. Symbols represent
means, and error bars indicate S.E. The asterisk (*) indicates statistically significant difference compared with
WT, and thenumber symbol (#) indicates statistically significant difference comparedwith Scn1aRH/ (p	 0.05).
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increased neuronal excitability (9, 11, 31, 32) and others pre-
dicting decreased neuronal excitability (9, 12, 13). It was not
known fromstudies in heterologous systemswhether themuta-
tions primarily affect excitatory or inhibitory neurons. Results
from our analysis of the biophysical properties of the R1648H
mutation in neurons from the knock-in mice suggest that the
primary effect of this mutation is to delay recovery from inac-
tivation and, thus, decrease the firing of inhibitory neurons.
Impairment of inhibition could be a general effect of SCN1A
mutations, but analyses of mouse models with other Scn1a
mutations are needed to determine whether this is a consistent
mechanism.
Studies of two complete loss-of-functionmutations of Scn1a
in mouse models of SMEI also showed diminished GABAergic
interneuron function. Heterozygotes for a knock-out mutation
of Scn1a displayed reducedNav1.1 channel expression, reduced
sodium currents, and an inability to sustain repetitive firing in
GABAergic interneurons of the cortex and hippocampus (15,
16). It is interesting that the R1648H homozygotes exhibit a
time course of seizure initiation and progression to lethality
that is very similar to the homozygous nullmice, demonstrating
a profound reduction of in vivo function as a result of thismuta-
tion. This was unexpected given the relatively small effects
observed in heterologous systems. We propose that decreased
excitability of the inhibitory circuitry is a major factor contrib-
uting to seizure generation in mouse models of GEFS and
SMEI and, by extension, GEFS and SMEI patients. A similar
mechanism may also underlie other SCN1A-derived disorders.
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